STAT3 and neoplasm: An important implication is that therapeutic blockade of a single cytokine or its receptor may not be sufficient to abrogate STAT3 signaling and acquired chemoresistance in tumor cells that are subjected to multiple cytokine stimuli that exist in the TME.